What Researchers Did
Researchers tested whether giving hyperbaric oxygen treatment soon after a burn injury changes early healing markers compared to standard care.
What They Found
This randomized pilot study assigned 17 adult patients with burns under 40% of their body surface to a control group (9 patients) or a hyperbaric oxygen group (8 patients), and found no significant effect of early HBOT on burn depth or on inflammatory markers such as white blood cell count and several cytokines. White blood cell count and cytokines including interleukin-1beta, interleukin-4, interleukin-6, interleukin-10 and interferon-gamma were significantly elevated 24 hours after the burn, but HBOT did not significantly change these levels. Two patients in the HBOT group and four in the control group developed positive bacterial cultures in their burn tissue, though the abstract does not report whether this difference was statistically significant. The authors note this finding suggests HBOT may possibly have a broad-spectrum antimicrobial effect worthy of further study, but describe this as a direction for future research rather than a proven effect.
What This Means for Canadian Patients
This pilot study found that hyperbaric oxygen given within 24 to 48 hours of a burn did not significantly change measured inflammation or burn depth compared to standard care. A possible antimicrobial signal was noted by the authors as worth investigating further, but was not established as a proven benefit in this small trial.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study recruited far fewer patients than planned due to slower than anticipated enrollment, making it a small pilot trial with limited ability to detect real effects.